News
Looking to take a flier on a stock? Consider the beaten down Air Canada. That’s the opinion of National Bank Financial ...
Following the company’s third quarter results, Haywood analyst Neal Gilmer has lowered his price target on Tilray Brands ...
Ventum Capital Markets analyst Rob Goff thinks he has found a tariff turmoil winner in Calian Group (Calian Group Stock Quote ...
New year, new CEO. Can Lip-Bu Tan make a difference for Intel ( Intel Stock Quote, Chart, News, Analysts, Financials ...
After taking a long look at the inquiry into Circle Medical’s billing practices by the U.S. Attorney’s Office, Raymond James ...
The new go-private price for Converge Technology Solutions is $6.00 and Ventum Capital Markets analyst Rob Goff thinks that ...
Following a key product update, Raymond James analyst Michael W. Freeman remains bullish on Medexus Pharmaceuticals ...
As reported by the Globe and Mail, McReynolds April 9 maintained his “Sector Perform” rating on BCE while cutting his price target on the stock from $39.00 to $37.00. The analyst says visibility has ...
He’s has a “Buy” rating on the stock, but TD Cowen analyst Vince Valentini thinks 2025 could be a rocky road for Rogers ...
Fund manager Greg Newman of Newman Group ScotiaMcLeod says he is “going out on a limb” by making Telus one of his top picks.
The biggest Liberation Day winner”. That’s where Citi analyst James Hardiman thinks BRP stands in the North American travel ...
Delayed financials from WELL Health mean an opportunity for investors, says Ventum Capital Markets analyst Rob Goff.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results